Scale-up– tag –
-
Business Trends
Äio and TFTAK Secure €1.94M for ‘DigiFoundry 2.0’ Project to Accelerate Waste-Derived Microbial Fat Production via AI-Driven Digital Platform
European Biotechnology Estonia Overview Äio and TFTAK have received €1.94 million in funding for their 'DigiFoundry 2.0' project, an AI-driven digital platform aimed at accelerating waste-derived microbial fat production. This three-year... -
Cell Culture Technology
Northway Biotech Opens Landmark €61M CDMO in Lithuania, Set to Drive European Cell and Personalized Medicine Manufacturing Scale-Up
chemanager-online.com Lithuania Overview Northway Biotech has launched a state-of-the-art €61 million Contract Development and Manufacturing Organization (CDMO) in Vilnius, Lithuania, specifically designed for cell therapy and personaliz... -
Market Trends
Evolving Economics of Single-Use Biomanufacturing: Large-Scale Bioreactors and Process Intensification Expand Commercial Production Strategies
Pharma's Almanac USA Overview The economics of single-use biomanufacturing are increasingly dependent not just on bioreactor volume but on utilization, process productivity, and annual throughput. Specifically, the introduction of larger... -
Market Trends
Leman Biotech Raises RMB 200M (USD 29M) Series A+ to Advance Ultra-Low-Dose Metabolically Armored CAR-T to Phase I Trials and Automated Manufacturing Scale-Up
Insight, China's Pharmaceutical Industry China Overview Leman Biotech has secured RMB 200 million (approximately USD 29 million) in Series A+ funding to advance Phase I trials of its ultra-low-dose metabolically armored CAR-T cell therap... -
Market Trends
Indian Pharma Accelerates Digital Bioprocessing Adoption: Digital Twins Optimize Bioreactor Performance and Mitigate Scale-Up Risks
BioSpectrum India India Overview Indian pharmaceutical companies are accelerating the adoption of digital bioprocessing tools, with a significant focus on digital twin technology to optimize manufacturing. Digital twins accurately simula... -
Market Trends
AI and Digital Twins Accelerate Cultivated Meat Commercialization: Bioprocess Optimization Drives Cost Reduction and Productivity
Food Engineering USA Overview A hybrid model digital twin strategy, combining AI with mechanistic bioprocess modeling, is emerging as an indispensable tool for commercially scaling cultivated meat production. These virtual models optimiz... -
New Technology
Celvivo Secures $6.6M to Propel Advanced 3D Cell Culture Platform, Appoints New CEO for Commercial Scale-Up
Dealroom News Denmark Overview Danish biotech Celvivo has raised $6.6 million from a mix of existing and new investors, earmarked for the accelerated commercial expansion of its ClinoStar 3D cell culture platform. This platform, which ge... -
Market Trends
The Bioreactor Scaling Conundrum: Navigating Flexibility, Yield, and Design Trade-offs in Biopharmaceutical Manufacturing
Nature Partnerships International Overview Scaling bioprocess production in bioreactors presents a formidable challenge, characterized by inherent trade-offs between flexibility, cell yield, and process design. Bioreactor specifications ... -
Cell Culture Technology
Functional Polymer FP003B Maximizes Cell Yield in Microcarrier MSC Culture by Suppressing Aggregation, Frontiers Reports Breakthrough
Frontiers Switzerland Overview A new study in Frontiers proposes a breakthrough method using functional polymer 003B (FP003B) to significantly inhibit excessive aggregation of microcarriers/mesenchymal stromal cells (MSCs) and enhance ce... -
New Technology
20 Years of iPSCs: From Bespoke Models to Standardized Biologic Medicines, as Reviewed by Nature Biotechnology
Nature Biotechnology / Stem Cell Reports (via Facebook) International Overview Celebrating the 20th anniversary of iPSC discovery, Nature Biotechnology and Stem Cell Reports reviewed the technology's evolution from bespoke experimental m...